Genus (LON:GNS) Announces Quarterly Earnings Results

Genus (LON:GNS) issued its quarterly earnings data on Thursday. The company reported GBX 110.30 EPS for the quarter, Digital Look Earnings reports. Genus had a net margin of 7.07% and a return on equity of 9.70%.

Here are the key takeaways from Genus’ conference call:

• FY 2026 results were strong: adjusted profit before tax and adjusted EPS each rose 35%, while free cash flow increased to £62 million and leverage fell to 0.4x.
• Genus announced a £60 million share buyback for FY 2027 and recommended a 10% increase in the full-year dividend to 35.2 pence per share, reflecting confidence in cash generation and future growth.
• PIC delivered broad-based growth, including 52% royalty-revenue growth in China and market-share gains, while the new China joint venture is expected to support further expansion in the world’s largest porcine market.
• PRP regulatory progress continued with approvals or favorable determinations in Argentina, Canada, Uruguay, and Peru; commercialization is now beginning in selected Latin American markets, although approvals in Mexico and China remain pending.
• Management expects FY 2027 underlying adjusted profit before tax to be only moderately higher, with growth weighted toward the second half due to weak agricultural markets, North American disease pressures, lower Brazilian growth, depressed dairy conditions, and higher PRP and product-development costs.

Genus Trading Down 5.9%

Shares of GNS traded down GBX 132 during midday trading on Thursday, hitting GBX 2,102. The stock had a trading volume of 1,507,223 shares, compared to its average volume of 775,234. Genus has a 1 year low of GBX 1,943 and a 1 year high of GBX 3,220. The firm has a market cap of £1.40 billion, a PE ratio of 29.61, a price-to-earnings-growth ratio of 2.87 and a beta of 0.90. The company has a debt-to-equity ratio of 51.73, a current ratio of 2.25 and a quick ratio of 1.08. The stock’s 50 day moving average is GBX 2,223.11 and its 200 day moving average is GBX 2,382.24.

Analyst Ratings Changes

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 3,350 price target on shares of Genus in a report on Thursday. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of GBX 3,216.67.

Insider Activity

In other news, insider Celia Baxter purchased 2,336 shares of the company’s stock in a transaction that occurred on Friday, June 26th. The stock was purchased at an average cost of GBX 2,140 per share, with a total value of £49,990.40. Company insiders own 0.71% of the company’s stock.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.